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Munc13-1 is a presynaptic protein activated by calcium, calmodulin, and diacylglycerols
(DAG) that is known to enhance vesicle priming. Doc2B is another presynaptic protein
that translocates to the plasma membrane (PM) upon elevation of internal calcium con-
centration ([Ca2+]i) to the submicromolar range, and increases both spontaneous and
asynchronous release in a calcium-dependent manner. We speculated that Doc2B also
recruits Munc13-1 to the PM since these two proteins have been shown to interact phys-
iologically and this interaction is enhanced by Ca2+. However, this calcium-dependent
co-translocation has never actually been shown.To examine this possibility, we expressed
both proteins tagged to fluorescent proteins in PC12 cells and stimulated the cells to inves-
tigate the recruitment hypothesis using imaging techniques.We found that Munc13-1 does
indeed translocate to the PM upon elevation in [Ca2+]i, but only when co-expressed with
Doc2B. Interestingly, Munc13-1 co-translocates at a slower rate than Doc2B. Moreover,
while Doc2B dislocates from the PM as soon as the [Ca2+]i returns to basal levels, Munc13-
1 dislocates at a slower rate and a fraction of it accumulates on the PM.This accumulation
is more pronounced under subsequent stimulations, suggesting that Munc13-1 accumula-
tion builds up as some other factors accumulate at the PM. Munc13-1 co-translocation and
accumulation was reduced when its mutant Munc13-1H567K, which is unable to bind DAG,
was co-expressed with Doc2B, suggesting that Munc13-1 accumulation depends on DAG
levels. These results suggest that Doc2B enables recruitment of Munc13-1 to the PM in
a [Ca2+]i-dependent manner and offers another possible Munc13-1-regulatory mechanism
that is both calcium- and Doc2B-dependent.
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INTRODUCTION
Munc13-1 is a key player in the final stages of exocytosis. It is a
relatively large protein (1,735 aa) with several distinct domains
(1). Its Mun domain (aa 859–1531) is responsible for the crucial
role of Munc13-1 in exocytosis: the conversion of syntaxin to its
open form. This open form of syntaxin interacts with SNAP-25 to
form a heterodimer; the heterodimer then interacts with synap-
tobrevin to form the SNARE complex, which holds the vesicle in
close proximity to the plasma membrane (PM) and enables effi-
cient fusion. Munc13-1 has an active C1 domain [aa 567–616 (1,
2)] and has been shown to translocate to the PM upon TPA/PMA
stimulation (3). Munc13-1 also has three active C2 domains (4–8),
and it interacts with members of the double-C2 domain (Doc2)
protein family via residues 851–1461 (3).
Doc2A and B are high-affinity sensors of internal calcium con-
centration ([Ca2+]i), containing tandem C2 domains that are
responsible for their Ca2+-dependent PM targeting and that pro-
mote priming and fusion (9, 10). Doc2A interacts with Munc13-1
through its Munc13-interacting domain (Mid, aa 13–37), which
is highly conserved in Doc2B [92%, (3)]. The interaction between
Munc13 and Doc2 has been demonstrated in both cell-free and
intact cell systems. In the yeast two-hybrid system, Munc13-1 and
Munc13-2 were shown to interact with both Doc2A and Doc2B
(3). Co-immunoprecipitation of Munc13-1 with Doc2A from
PC12 cells was markedly enhanced when the cells were stimulated
by TPA or high K+ in the presence of extracellular calcium (3).
A growth hormone assay in PC12 suggested that this interaction
has a physiological role; overexpression of the Doc2-interacting
domain of Munc13 reduced the Ca2+-dependent exocytosis from
PC12 cells, and co-expression with Doc2 suppressed this reduc-
tion (3). However, expression of Mid alone in PC12 cells had no
effect on the number of docked vesicles (11).
The physiological relevance of this interaction was then further
tested in neurons. Introduction of the Mid peptide into presynap-
tic neurons of cholinergic synapses reversibly inhibited synaptic
transmission evoked by action potentials (12). In contrast, the
scrambled Mid peptide did not inhibit synaptic transmission.
Recordings from the calyx of Held revealed that presynaptic load-
ing of a synthetic Mid peptide significantly attenuates phorbol-
ester (PE) induced synaptic potentiation, whereas the scrambled
Mid peptide had no effect (13).
Imaging experiments revealed that Doc2B translocates to the
PM when it is co-expressed with Munc13-1 following PE appli-
cation (14). Doc2A and Munc13-4 relocated to the cell periphery
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together with the secretory lysosome marker CD63 upon Ag stim-
ulation in a calcium-free medium (15). This interaction depended
on the Mid domain of Doc2A although C2B also seemed to play
a role (15). Both Doc2B and Munc13-1 are expressed in chromaf-
fin cells (10, 16). Based on the fact that Doc2B translocates to the
PM upon calcium elevation and interacts with Munc13-1, and on
the above data, we hypothesized that Doc2B will efficiently recruit
Munc13-1 to the PM in a [Ca2+]i-dependent manner. We found
that Munc13-1 co-translocates to and accumulates at the PM when
co-expressed with Doc2B in a calcium-dependent manner.
MATERIALS AND METHODS
CELL LINES
PC12 cells (a generous gift from Dr. Nicolas Vitale, CNRS-
UPR, Strasbourg, France) were grown in DMEM (Biologi-
cal Industries, Beit Haemek, Israel) supplemented with glucose
(4,500 mg/l) and l-glutamine (Gibco-BRL), and containing 5%
(v/v) fetal calf serum, 10% (v/v) horse serum, and 100 U/ml peni-
cillin/streptomycin (Biological Industries). The cells were split
regularly to maintain confluence and were kept in a 37°C, 5%
CO2-humidified incubator. Transfection was performed using
Lipofectamine™ 2000 (Invitrogen) according to the manufac-
turer’s instructions at a 2:3 (DNA:reagent) ratio. Cells were imaged
16–32 h after transfection.
COS-7 cells were grown in DMEM supplemented with 10%
fetal calf serum, 2 mM l-glutamine, and 100 U/ml penicillin-
streptomycin. The cells were split regularly to maintain confluence
and were kept in a 37°C, 5% CO2-humidified incubator. Trans-
fection was performed using Jet-PEI (PolyPlus Transfection, New
York, NY, USA) according to the manufacturer’s instructions at a
1:2 (DNA:reagent) ratio.
DNA CONSTRUCTS
All plasmids encoding fluorescently labeled Doc2B and the
Doc2B–glutathione-S-transferase (GST) plasmids were a gener-
ous gift from Dr. Alexander J. Groffen (Vrije Universiteit, Ams-
terdam, The Netherlands) and the control GST construct was a
generous gift from Prof. Joel Hirsch (Tel Aviv University, Israel).
The sequences of all constructs were verified by automated DNA
sequencing. Munc13-1 plasmids are a kind gift from Prof. N. Brose
(Max-Plank institute, Gottingen, Germany).
WESTERN BLOTTING
Western blot experiments were performed according to standard
procedures. In general, protein extracts (for overexpression exper-
iments ∼10µg protein, for endogenous experiments ∼100µg
protein) were loaded on an SDS-polyacrylamide (8 or 11%) gel
and electrophoresed with a constant current of 30 mA for each
gel. The proteins from the gel were transferred to a nitrocellu-
lose membrane by electroblotting at a constant current of 400 mA
for 1 h. The membrane was incubated in blocking solution (5%
milk powder) overnight at 4°C with gentle agitation. After five
washes, we incubated the membrane with primary rabbit anti-
Doc2B antibody for 1 h at room temperature (diluted 1:500 in
1% BSA with 0.05% azide). The membrane was washed five
times and incubated with the relevant secondary horseradish
peroxidase-conjugated antibody for 45 min at room tempera-
ture (diluted 1:15,000 in milk). Then the membrane was washed
six times, and detection was performed using enhanced chemi-
luminescence solution (Pierce) and exposure to Super RX film
(Fuji).
CO-TRANSLOCATION EXPERIMENTS
For the translocation experiment, PC12 cells were plated on
glass coverslips, transfected with different combinations of plas-
mids (see Results for details) encoding fluorescently tagged
proteins – Doc2Bwt–mRFP, Doc2BD218,220N–mRFP, Doc2BMid–
mRFP, Munc13-1wt–EGFP, Munc13-1H567K–EGFP, or EGFP alone
using Lipofectamine 2000. Imaging was performed 16–32 h post-
transfection. Cells were perfused constantly with external solution
and excited using a high K+ solution (70 mM) as described in
Groffen et al. (9). The imaging setup consisted of an Olympus
IX-70 inverted microscope with a 60× total internal reflection flu-
orescence (TIRF) objective (Olympus), a TILL Photonics TIRF
condenser (Gräfelfing, Germany), two solid-state lasers (Laser
Quantum, Stockport, UK) emitting at 473 and 532 nm, an Andor
Ixon 887 EMCCD camera (Belfast, Northern Ireland), and a dual-
view beam-splitting device (Optical Insights, Roper Bioscience,
Tucson, AZ, USA). Time-lapse images were taken every 300 ms.
The equipment was controlled by Metamorph software (Molecular
Devices, Downingtown, PA, USA), which was also used to perform
the analysis. Confocal images were recorded using a 63× objec-
tive of Zeiss LSM 510 META microscope equipped with 30 mW
488 nm Argon laser and 15 mW 561 nm DPSS laser.
RESULTS
Doc2B AND Munc13-1 CO-TRANSLOCATE UPON ELEVATION OF [Ca2+]i
To investigate our hypothesis that co-expression of Doc2Bwt and
Munc13-1 results in co-translocation of both proteins to the PM
upon [Ca2+]i elevation, we expressed Munc13-1 fused to EGFP in
PC12 cells together with Doc2Bwt fused to mRFP. The cells were
subjected to three short (20 s) KCl applications (with relaxation
times between each application) which caused elevation of [Ca2+]i
and translocation of Doc2B and Munc13-1 to the PM (Figure 1).
In the absence of calcium, the translocation of both proteins was
abolished suggesting it is calcium dependent (Figure S1 in Sup-
plementary Material). Munc13-1 translocated to the PM upon
elevation in [Ca2+]i, but only when co-expressed with Doc2Bwt
(Figures 1 and 2). When Munc13-1 was expressed in PC12 cells
without Doc2B it did not translocate to the PM upon high K+
stimulation (Figure S2 in Supplementary Material). To establish a
more quantitative connection between Doc2Bwt translocation and
that of Munc13-1wt, we repeated this experimental protocol using
TIRF microscopy, focusing on the fluorescence of the cell’s lower
PM (Figure 2A). Co-translocation of Munc13-1wt and Doc2Bwt
was clearly seen in the TIRF plane (Figure 2A). Examining the
translocation kinetics revealed that Munc13-1wt translocates to
the PM at a slower rate than Doc2Bwt (Figure 2B; n= 13). More-
over, Munc13-1wt translocation, at least in the second and third
application, peaked when Doc2Bwt was already in its dislocating
phase (Figure 2B). Munc13-1 dislocation also seemed to occur
at a slower rate than that of Doc2B. It is interesting to note that
although Doc2Bwt fluorescence returned to its initial level after
each application, Munc13-1wt started to accumulate at the PM
after the first application, though this became more apparent after
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FIGURE 1 | Co-translocation of Doc2Bwt and Munc13-1wt. Confocal
images of a PC12 cell co-expressing Munc13-1wt-EGFP (left) and
Doc2Bwt-mRFP (middle). Merged images presented on the right. (A) At
basal calcium both proteins have a cytoplasmic distribution. (B) At the initial
phase of the calcium elevation (2–10 s after KCl application), translocation of
Doc2B occurs, but Munc13-1 is still mainly cytoplasmic. (C) Munc13-1wt
translocation is seen only at later stages of the experiment when Doc2B
concentration on the membrane is higher (10–20 s after KCl application).
the second and third application. It is also interesting to note that
although the translocation of Munc13wt to the PM appeared rather
uniform in the confocal images (Figure 1), it showed a patchy
appearance in TIRF images (Figure 2A). This patchy pattern was
not unique to Munc13-1wt’s Doc2Bwt-dependent translocation; a
similar dotted staining pattern appeared in PE-induced transloca-
tion of Munc13-1wt (Figure 3). As PE mimics the interaction of
Munc13-1 with diacylglycerol (DAG), it is possible that when on
the PM, Munc13-1 interacts with DAG.
We have previously shown that a mutated form of Doc2B–
Doc2BD218,220N is constitutively associated with the PM. We
therefore examined the effect of Doc2BD218,220N on Munc13-
1wt’s distribution in the cell. Co-expression of these two proteins
resulted in the constant translocation of both Doc2BD218,220N and
Munc13-1wt (Figure 4). As in Figure 2, Munc13-1wt showed a
patchy pattern at the PM.
CO-TRANSLOCATION OF Munc13-1 AND Doc2B DEPENDS ON THE
Doc2B–Munc13-1 INTERACTION AND ON Munc13-1s C1 DOMAIN
To determine whether the Mid domain of Doc2B is responsible
for the co-translocation of Doc2B and Munc13-1, we repeated
the translocation experiment with Doc2B harboring a scrambled
Mid domain (Doc2BMid), and examined if this mutation abol-
ishes translocation of Munc13-1wt. Scrambling the Mid domain
of Doc2B disrupted the interaction with Munc13-1wt [Figure S3
in Supplementary Material; (12)]. Although the Mid mutation
disrupted most of Munc13-1wt’s translocation, some degree of
translocation still existed (Figure 5). The translocation was barely
detected in the first KCl application but in later applications,
FIGURE 2 | Co-translocation of Doc2Bwt–mRFP and Munc13-1wt–EGFP
in theTIRF plane. (A) TIRF images of a PC12 cell expressing
Munc13-1wt–EGFP (upper panel) and Doc2Bwt–mRFP (lower panel). From
left to right: basal state, beginning of translocation, maximum translocation,
and back to basal state. (B) Quantification graph of the translocation
kinetics observed in the cell’s lower PM. Red line indicates Doc2Bwt–mRFP,
green line indicates Munc13-1wt–EGFP (n=13). Yellow arrows indicate KCl
application.
FIGURE 3 | PE stimulation of PC12 cell co-expressing Doc2Bwt–mRFP
and Munc13-1wt–EGFP. (A) Epi-fluorescence images of a PC12 cell
co-expressing Munc13-1wt–EGFP (upper panel) and Doc2Bwt–mRFP (lower
panel) after PE application. Munc13-1wt translocated to the PM while
Doc2Bwt did not. (B) TIRF images of a PC12 cell co-expressing
Munc13-1wt–EGFP (upper panel) and Doc2Bwt–mRFP (lower panel) after PE
application. Munc13-1wt translocated to the PM while Doc2Bwt did not.
Note the patchy nature of Munc13-1wt ’s translocation at the PM.
some Munc13-1 showed translocation and accumulation on the
PM. These results suggest that the Mid domain is important for
Munc13-1 co-translocation; however, Munc13-1 also accumulates
slowly at the PM without the interaction with Doc2B Mid domain,
possibly via its C1–DAG interaction.
The C1 domain of Munc13 is important for its membrane-
attachment ability via its interaction with DAG (17, 18), and we
therefore examined whether the C1 domain is also important for
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FIGURE 4 | A PC12 cell co-expressing Doc2BD218,220N–mRFP and
Munc13-1wt. (A) Epi-fluorescence images of a PC12 cell co-expressing
Doc2BD218,220N–mRFP (left) and Munc13-1wt–EGFP (right). (B) TIRF images of
a PC12 cell co-expressing Doc2BD218,220N–mRFP (left) and Munc13-1wt–EGFP
(right).
FIGURE 5 | Quantification of co-translocation of Doc2BMid–mRFP and
Munc13-1wt–EGFP. Quantification graph of the TIRF experiment
demonstrating translocation of Doc2BMid and low translocation of
Munc13-1wt during the first KCl application (n=8). Munc13-1wt translocation
becomes more pronounced at the second and third KCl application but still
lower compared to co-expression with Doc2Bwt. Black line marks the value
of 1 (no translocation). Yellow arrows indicate KCl application.
Doc2B-induced Munc13-1 translocation and accumulation. We
used a Munc13-1 mutant that does not bind DAG (Munc13-
1H567K) and cannot translocate to the PM upon PE stimu-
lation, and examined whether Doc2B could induce Munc13-
1H567K translocation. Munc13-1H567K displayed lower transloca-
tion ability than Munc13-1wt (Figure 6 compared to Figure 2)
and did not accumulate on the PM like its wild-type counter-
part. Thus, it seems that the initial translocation of Munc13-
1 depends on interaction with Doc2B and soon after, the
C1–DAG interaction determines the accumulation of Munc13-1
at the PM.
FIGURE 6 | Co-translocation of Doc2Bwt–mRFP and
Munc13-1H567K–EGFP. Quantification graph of the TIRF experiment
demonstrating translocation of Doc2Bwt and low translocation of
Munc13-1H567K (n=14). No accumulation of Munc13-1H567K is detected.
Yellow arrows indicate KCl application.
DISCUSSION
Munc13-1 is a key player in the synapse; the activity of this mul-
tidomain protein is tightly regulated by many factors, including
calmodulin (5, 19, 20), DAG (18, 21), and Ca2+ in a PIP2 depen-
dent manner (7). We show here that Doc2B recruits Munc13-1 to
the PM in a Ca2+-dependent manner, thereby suggesting another
possible Munc13-1-regulatory mechanism.
The Doc2 family of proteins interacts with the Munc13 family
of proteins primarily via the Mid domain, located within the N-
terminal domain of Doc2 (3, 12, 14, 15, 22). Doc2 translocates to
the PM upon elevation of [Ca2+]i. Munc13-1, on the other hand,
does not translocate to the PM upon calcium elevation. How-
ever, when co-expressed with Doc2B, Munc13-1 co-translocates
to the PM following Doc2B. This translocation could not be
detected with endogenous Doc2B and Munc13-1 as these pro-
teins are expressed in low levels in neuroendocrine cells (10, 16,
19) and such translocation, if occurs might be undetectable under
these conditions. Munc13-1’s translocation is most likely medi-
ated through the Mid domain as reflected by its reduction upon
mutation in the Mid domain. When the elevation of calcium is
brief, Munc13-1 translocation is reversible, dislocating back to
the cytosol after Doc2B dislocation. However, following repeated
stimulations, Munc13-1 starts to accumulate at the PM even after
Doc2B has dislocated back to the cytosol. This accumulation was
abolished when a Munc13-1 mutant that does not bind DAG
(Munc13-1H567K) was co-expressed with Doc2B suggesting that
the C1–DAG interaction determines Munc13-1’s accumulation at
the PM. It is possible that during high-frequency activity, e.g., sus-
tained or intermittent depolarization, the level of DAG increases
(23). This would cause a more stable interaction of Munc13-1
with the PM via its C1 domain, anchoring it to the PM, and
enabling its catalytic activity in the fusion step (2). Thus, accord-
ing to this working model, the activity of Munc13-1 at the PM
depends on the stimulation’s frequency and on Doc2B transloca-
tion, becoming more prominent during periods of high activity.
Doc2B has been recently shown to enhance neuronal network
activity by specifically increasing the firing rate within a neuronal
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burst (24). Therefore, it is possible that in addition to the direct
effect of Doc2B on asynchronous release, it also recruits Munc13-1
during periods of intense activity, which might also contribute to
the enhanced network activity. A similar mode of action has been
suggested for protein kinase C (PKC) activity (25). Many receptor
stimuli induce calcium signals prior to a more persistent increase
in DAG concentration. These calcium signals have only a minimal
effect on conventional PKC activity in the absence of DAG. How-
ever, in the presence of DAG, each calcium spike induces a more
pronounced activation cycle of conventional PKC.
Our data suggest that the interaction between Doc2B and
Munc13-1 depends on more than just the Mid domain of Doc2B
since a small degree of translocation was still observed when
Munc13-1 was co-expressed with Doc2BMid. We hypothesize that
this interaction is also dependent on the C1 domain of Munc13-
1 as it has been reported that deleting this domain increases
Munc13-1’s interaction with Doc2B (3). It is also possible that the
C2B of Doc2B contributes to this interaction, as has been recently
suggested for Doc2A and Munc13-4 (15).
A previous study described co-translocation of Doc2Bwt and
Munc13-1wt upon PE stimulation (14). Such translocation was
not observed here, either in the epi-fluorescence or TIRF imaging.
Hence, the interaction of Munc13-1’s C1 domain with DAG at
the PM may compete with Doc2B binding to Munc13-1. There-
fore, stimulating the cells with PE caused Munc13-1’s translocation
but interfered with Doc2B translocation. These findings, together
with the observation that Munc13-1 reaches maximal transloca-
tion when Doc2B is already dislocating from the PM due to a
decrease in [Ca2+]i, suggest that the interaction of Munc13-1 with
DAG at the PM cannot occur when it is in a complex with Doc2B.
Therefore, DAG binding to Munc13-1 might disrupt Doc2B bind-
ing. These findings suggest that Doc2B recruits Munc13-1 to the
PM but once there, Munc13-1 associates through its C1 domain
with DAG and this reduces its interaction with Doc2B. Further
experiments will be needed to validate this hypothesis.
Co-expression of Doc2BD218,220N with Munc13-1wt revealed
that the two proteins are being constantly translocated to the PM,
yet the Doc2BD218,220N mutant could not support refilling dur-
ing repeated stimulations (10). Combining these two observations
suggests a possible physiological effect of the Doc2B–Munc13-
1 interaction: this complex needs to undergo an on–off cycle
from the PM to achieve a full priming effect. Another possible
explanation is that Munc13-1 needs to detach from Doc2B at the
PM to enable its priming effect. Taken together, our data sup-
port the hypothesis that Doc2B serves as a calcium-dependent
recruitment factor for Munc13-1 whereas at the PM, Munc13-1
interacts with DAG. This provides an activity-dependent recruit-
ment mechanism for two major synaptic proteins, Doc2B and
Munc13-1.
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Figure S1 | Doc2Bwt and Munc13-1wt do not translocate to the PM in the
absence of calcium. Epi-fluorescence images of a PC12 cell co-expressing
Doc2Bwt-mRFP (left) and Munc13-1wt-EGFP (center). Merged images presented
on the right. In the upper panel, the cell in its basal state. In the lower panel, the
cell after application of depolarizing high K+ solution without calcium (containing
0.1 mM EGTA). Note there is no evident change in the proteins distribution in
the cell.
Figure S2 | Munc13-1wt does not translocate to the PM in the absence of
Doc2B. Epi-fluorescence images of a PC12 cell expressing Munc13-1wt–EGFP,
before (left) and after (right) application of depolarizing high K+ solution. Note
there is no evident change in the protein’s distribution in the cell.
Figure S3 | GST pull-down assay of Doc2B N-terminal with Munc13-1. GST
fusion of the N-terminal of Doc2Bwt and N-terminal of Doc2BMid binding to
Munc13-1wt (Upper panel) and Munc13-1H567K (lower panel). Munc13-1wt and
Munc13-1H567K show binding only to N-terminal of Doc2Bwt and not to N-terminal
of Doc2BMid.
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